Impact of elosulfase alfa in patients with Morquio syndrome type A who have limited ambulation: An open-label, phase 2 study.

Paul R. Harmatz, Andrea Jester, Eugen Mengel, Marsha Treadwell, Barbara K. Burton, Kenneth I. Berger, Christian J. Hendriksz, Tarekegn Geberhiwot, Zlatko Sisic, Celeste Decker. Impact of elosulfase alfa in patients with Morquio syndrome type A who have limited ambulation: An open-label, phase 2 study. Molecular Genetics and Metabolism. 2016 Feb 1; 117(2):s55.

2016
https://researcherprofiles.org/profile/84746292

Paul R. Harmatz, Andrea Jester, Eugen Mengel, Marsha Treadwell, Barbara K. Burton, Kenneth I. Berger, Christian J. Hendriksz, Tarekegn Geberhiwot, Zlatko Sisic, Celeste Decker